These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 31553050)

  • 1. Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus.
    Burman RJ; Selfe JS; Lee JH; van den Berg M; Calin A; Codadu NK; Wright R; Newey SE; Parrish RR; Katz AA; Wilmshurst JM; Akerman CJ; Trevelyan AJ; Raimondo JV
    Brain; 2019 Nov; 142(11):3482-3501. PubMed ID: 31553050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus.
    Jones DM; Esmaeil N; Maren S; Macdonald RL
    Epilepsy Res; 2002 Aug; 50(3):301-12. PubMed ID: 12200221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus.
    Sivakumaran S; Maguire J
    Epilepsia; 2016 Feb; 57(2):222-32. PubMed ID: 26659482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
    Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cellular alterations in the hippocampus after status epilepticus.
    Macdonald RL; Kapur J
    Epilepsia; 1999; 40 Suppl 1():S9-20; discussion S21-2. PubMed ID: 10421557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of diazepam's discovery on the treatment and understanding of status epilepticus.
    Goodkin HP; Kapur J
    Epilepsia; 2009 Sep; 50(9):2011-8. PubMed ID: 19674049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice.
    Kaminski RM; Fu Z; Venkatesan K; Mazzuferi M; Leclercq K; Seutin V; Vicini S
    Neuropharmacology; 2011 Jun; 60(7-8):1098-108. PubMed ID: 20883706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures.
    Deeb TZ; Maguire J; Moss SJ
    Epilepsia; 2012 Dec; 53 Suppl 9(0 9):79-88. PubMed ID: 23216581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal.
    Joshi S; Rajasekaran K; Hawk KM; Brar J; Ross BM; Tran CA; Chester SJ; Goodkin HP
    Epilepsia; 2015 Sep; 56(9):1355-65. PubMed ID: 26248944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of convulsive status epilepticus in infants and children].
    Hubert P; Parain D; Vallée L
    Rev Neurol (Paris); 2009 Apr; 165(4):390-7. PubMed ID: 19264335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting with-no-lysine kinases enhances K+/Cl- cotransporter 2 activity and limits status epilepticus.
    Lee KL; Abiraman K; Lucaj C; Ollerhead TA; Brandon NJ; Deeb TZ; Maguire J; Moss SJ
    Brain; 2022 Apr; 145(3):950-963. PubMed ID: 34528073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bumetanide is not capable of terminating status epilepticus but enhances phenobarbital efficacy in different rat models.
    Töllner K; Brandt C; Erker T; Löscher W
    Eur J Pharmacol; 2015 Jan; 746():78-88. PubMed ID: 25445051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epileptic seizures in critically ill patients].
    Stasiukyniene V; Pilvinis V; Reingardiene D; Janauskaite L
    Medicina (Kaunas); 2009; 45(6):501-7. PubMed ID: 19605972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stiripentol in refractory status epilepticus.
    Grosenbaugh DK; Mott DD
    Epilepsia; 2013 Sep; 54 Suppl 6():103-5. PubMed ID: 24001087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.
    Fritsch B; Stott JJ; Joelle Donofrio J; Rogawski MA
    Epilepsia; 2010 Jan; 51(1):108-17. PubMed ID: 19682025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotide to GABA(A) receptor gamma2 subunit induces limbic status epilepticus.
    Karle J; Woldbye DP; Elster L; Diemer NH; Bolwig TG; Olsen RW; Nielsen M
    J Neurosci Res; 1998 Dec; 54(6):863-9. PubMed ID: 9856870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying status epilepticus.
    Noe KH; Manno EM
    Drugs Today (Barc); 2005 Apr; 41(4):257-66. PubMed ID: 16034490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive shifts of the GABAA receptor reversal potential due to altered chloride homeostasis is widespread after status epilepticus.
    Barmashenko G; Hefft S; Aertsen A; Kirschstein T; Köhling R
    Epilepsia; 2011 Sep; 52(9):1570-8. PubMed ID: 21899534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
    Niquet J; Nguyen D; de Araujo Furtado M; Lumley L
    Epilepsia Open; 2023 May; 8 Suppl 1(Suppl 1):S117-S140. PubMed ID: 36807554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam.
    Rice AC; DeLorenzo RJ
    Neuroscience; 1999; 93(1):117-23. PubMed ID: 10430476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.